The UK’s junior market has endured the same turbulence and uncertainty as its larger cousin since the coronavirus broke out in Europe in February. But, just like the FTSE, there are opportunities amid the gloom. Aim’s higher quality companies are proving resilient, while the abundance of pharmaceutical and biotechnology companies have come into their own during the pandemic.
Aim can be an exciting market for stock pickers. Here are five key things to understand before you take the plunge into the market.
To continue reading, register today
to enjoy limited access to the following:
- Daily trading news
- Funds coverage
- Features on big investment themes
- Comprehensive companies coverage
- Economic analysis